treat/number-needed-to-harm (NNT/NNH) with 95% confidence intervals was calculated. Heterogeneity was assessed using the X 2 and I 2 statistics.
To evaluate the analgesic efficacy and adverse effects of nefopam used for the relief of postoperative pain.
Searching MEDLINE, EMBASE, the Cochrane Library, WHOLIS (World Health Organization library database), the African Index Medicus and LILACS (Latin American and Caribbean Health Sciences Literature) were searched to January 2008. Search terms were reported. No language restrictions were applied. In addition, reference lists of retrieved studies were screened. Studies reported as abstracts were excluded.
Study selection
Randomised controlled trials (RCTs) that compared nefopam with an inactive control (placebo or no treatment) for the prevention of postoperative pain were eligible for inclusion. Trials had to assess pain outcomes or adverse effects. Trials of healthy volunteers and trials with fewer than 10 patients per treatment group were excluded. The review assessed pain intensity at rest and on movement or during coughing, and cumulative postoperative morphine consumption.
The included trials evaluated a variety of different nefopam treatment regimens including continuous intravenous infusion, single and repeat intravenous injection, single and repeat intramuscular injection and single oral dose. Cumulative doses ranged from 20mg to 160mg for intravenous regimens, from 45mg to 90mg for oral regimens, and from 20mg to 100mg for intramuscular regimens. Trials reported a variety of pain measures at various times postoperatively (from 60 minutes to 48 hours). Patients were adults undergoing a variety of surgical procedures including: major abdominal surgery; episiotomy; hip arthroplasty; gynaecological and orthopaedic surgery; and dental extraction.
The authors did not state how papers were selected for the review, or how many reviewers performed the selection.
Assessment of study quality
Validity was assessed using a modified four-item seven-point Oxford scale that evaluated randomisation, allocation concealment, blinding and description of withdrawals.
One reviewer assessed validity and this was independently checked by two other reviewers. Discrepancies were resolved by discussion.
Data extraction
Continuous outcomes were extracted as means and standard deviations or standard errors; authors were contacted for missing data. Where required, data were extracted from graphs. Zero to 10cm visual analogue scales (VAS) were converted to 0 to 100mm.
One reviewer extracted data and this was independently checked by two other reviewers.
Methods of synthesis
Pooled weighted mean differences (WMD) and relative risks (RR) with 95% confidence intervals (CI) were calculated using a fixed-effect model. Where treatment differences were statistically significant, the number-needed-to-
